Adam P. Runsdorf, 57, of Boca Raton, Florida, United States is an alumnus of Rutgers University in New Brunswick, New Jersey, USA. He is the owner and president of Woodfield Pharmaceutical LLC, which is based in Boca Raton.
In April 2014, Actavis Holdco US discontinued production of Actavis cough syrup due to its widespread abuse by recreational drug users. This increased the syrup’s street value to more than $3,000 per pint.
From April 2014 to August 2021, Runsdorf conspired with drug traffickers in Houston, Texas, to distribute misbranded and counterfeit cough syrup. He used his position as the Woodfield Pharmaceutical owner and president and his connections to enable drug traffickers in Houston, Texas, USA to produce thousands of gallons of counterfeit Actavis.
During the conspiracy, Byron A. Marshall, 43, of Houston communicated directly with Runsdorf about production of the counterfeit Actavis. Marshall paid Woodfield Pharmaceutical in cash only and the company’s employees mailed the cash directly to Runsdorf in Boca Raton.
Marshall used Woodfield Pharmaceutical’s manufacturing facility and employees in Houston to produce more than 500,000 pints of counterfeit Actavis, which were labeled to be nearly identical to the discontinued product. His drug trafficking organization sold the counterfeit drugs across 12 U.S. states namely Alabama, Arkansas, California, Florida, Georgia, Louisiana, Mississippi, Ohio, South Carolina, Tennessee, Texas and Wisconsin.
On August 22, 2022, Runsdorf pleaded guilty before U.S. Magistrate Judge Christine L. Stets to conspiracy, trafficking in counterfeit drugs and money laundering conspiracy. Marshall and five other codefendants have already pleaded guilty and are awaiting sentencing.
Categories: brands, Business & Technology, crimes, fitness & health, Lifestyle, NEWS, North America, Social Issues, United States
Leave a Reply